Lynn R. Webster, MD, FACPM, FASAM
Co-founder and Medical Director
Lifetree Clinical Research
Salt Lake City, Utah
Dr. Lynn Webster is board certified in anesthesiology and pain medicine and is also certified in addiction medicine. In his private practice, he treats chronic pain patients, many of whom have complex diagnoses. He also detoxes opioid-addicted patients. This dual role lends Dr. Webster a valuable perspective. He is dedicated to treating patients in pain while simultaneously working to minimize the potential for abuse and addiction.
Dr. Webster is co-founder and medical director of Lifetree Clinical Research. His research interests are diverse. He has been keenly interested in developing safer and more effective therapies for chronic pain and addiction.
Dr. Webster earned his doctorate of medicine from the University of Nebraska Medical Center and completed his residency in the University of Utah Medical Center’s Department of Anesthesiology. He lectures extensively on the subject of preventing opioid abuse and criminal diversion in chronic pain patients, and he has authored over 100 scientific abstracts, journal articles and the recently published book Avoiding Opioid Abuse While Managing Pain: A Guide for Practitioners. This book was written for clinicians who prescribe opioids as a guide to sort out the clinical, regulatory, and ethical issues associated with the prescribing of opioid analgesics. It includes step-by-step protocols for assessing patients for the risk of opioid abuse as well as for legally protecting the opioid prescriber.
He is the co-founder of LifeSource, a non-profit foundation established in 2006 to educate physicians, patients, and communities on health issues (with an emphasis on pain-related, scientific and social issues), as well as fund and conduct research that will discover new solutions and hope for improved life. LifeSource’s first project is entitled “Zero Unintentional Deaths.” The campaign was developed to educate physicians, chronic pain sufferers and all communities about the increasingly serious issue of unintentional overdose deaths relating to methadone and other prescription medications. It aims to eliminate unintentional overdoses from prescription medication.
Dr. Webster is currently on the Board of Directors for the American Academy of Pain Medicine and the National Pain Foundation. He was also instrumental in launching the Utah chapter of the American Academy of Pain Medicine. This organization seeks to achieve high medical standards, improve access to pain care and educate all interested parties about the many pain-related scientific and social issues.
Financial Disclosure
Dr. Lynn Webster has received honoraria as a consultant from Ameritox, Ltd.; Cephalon, Inc.; King Pharmaceuticals, Inc.; and Medtronic, Inc. He has received grant support related to research activities from Arcion Therapeutics, Inc.; Advanced Bionics; Cephalon; CoMentis, Inc.; F. Hoffmann-La Roche Ltd.; Forest Laboratories, Inc.; Hisamitsu Pharmaceutical Co., Inc.; King Pharmaceuticals, Inc.; Medtronic; Merck & Co., Inc.; Myriad Pharmaceuticals; Nektar Therapeutics; NeurogesX; Pfizer Inc.; Wyeth; and XenoPort;. In addition, he has received honoraria related to formal advisory activities from Ameritox; King; Nektar; Nervo; Neuromed Pharmaceuticals Inc.; and Purdue Pharma L.P.



